FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:292-294 January 15, 2009 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Tonino, P. A.L. PubMed Citation

The broad goals of treatment for patients with coronary artery disease are improvement in survival and a reduction in the risk of myocardial infarction and symptoms of coronary disease. The circumstances under which revascularization with the use of percutaneous coronary intervention (PCI) or bypass surgery is needed, and the optimal means of providing revascularization for patients with multivessel coronary disease, remain enigmatic. Much of our evidence base is badly outdated.^1,2 Fortunately, several large clinical trials are under way, and early results of some of these trials are available. For example, the 1-year results of the SYNTAX (Synergy between Percutaneous Coronary . . . [Full Text of this Article]

Source Information

From the Department of Cardiology, Cleveland Clinic, Cleveland.

This article has been cited by other articles:

• (2009). Directing Coronary Intervention Using Fractional Flow Reserve. Journal Watch Cardiology 2009: 1-1 [Full Text]